» Articles » PMID: 37509711

Airway Epithelium Senescence As a Driving Mechanism in COPD Pathogenesis

Overview
Journal Biomedicines
Date 2023 Jul 29
PMID 37509711
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular senescence is a state of permanent cell cycle arrest triggered by various intrinsic and extrinsic stressors. Cellular senescence results in impaired tissue repair and remodeling, loss of physiological integrity, organ dysfunction, and changes in the secretome. The systemic accumulation of senescence cells has been observed in many age-related diseases. Likewise, cellular senescence has been implicated as a risk factor and driving mechanism in chronic obstructive pulmonary disease (COPD) pathogenesis. Airway epithelium exhibits hallmark features of senescence in COPD including activation of the p53/p21WAF1/CIP1 and p16INK4A/RB pathways, leading to cell cycle arrest. Airway epithelial senescent cells secrete an array of inflammatory mediators, the so-called senescence-associated secretory phenotype (SASP), leading to a persistent low-grade chronic inflammation in COPD. SASP further promotes senescence in an autocrine and paracrine manner, potentially contributing to the onset and progression of COPD. In addition, cellular senescence in COPD airway epithelium is associated with telomere dysfunction, DNA damage, and oxidative stress. This review discusses the potential mechanisms of airway epithelial cell senescence in COPD, the impact of cellular senescence on the development and severity of the disease, and highlights potential targets for modulating cellular senescence in airway epithelium as a potential therapeutic approach in COPD.

Citing Articles

A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches.

Iskandar M, Xiao Barbero M, Jaber M, Chen R, Gomez-Guevara R, Cruz E Cancers (Basel). 2025; 17(2).

PMID: 39858038 PMC: 11764024. DOI: 10.3390/cancers17020257.


Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics development.

Devulder J Chin Med J Pulm Crit Care Med. 2024; 2(3):133-141.

PMID: 39403409 PMC: 11471098. DOI: 10.1016/j.pccm.2024.08.007.


BRD4 plays an antiaging role in the senescence of renal tubular epithelial cells.

Bo Y, Zhang Y, Wei L, Pei X, Zhu B, Zanoli L Transl Androl Urol. 2024; 13(6):1014-1023.

PMID: 38983468 PMC: 11228682. DOI: 10.21037/tau-24-214.


Association Between Urinary Phthalate Metabolites and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.

Li X, Li Z, Ye J, Ye W Int J Chron Obstruct Pulmon Dis. 2024; 19:1421-1431.

PMID: 38948906 PMC: 11212814. DOI: 10.2147/COPD.S459435.


Unlocking the Future: Pluripotent Stem Cell-Based Lung Repair.

Goecke T, Ius F, Ruhparwar A, Martin U Cells. 2024; 13(7.

PMID: 38607074 PMC: 11012168. DOI: 10.3390/cells13070635.


References
1.
To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T . Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182(7):897-904. PMC: 2970861. DOI: 10.1164/rccm.200906-0937OC. View

2.
Ganesan S, Faris A, Comstock A, Chattoraj S, Chattoraj A, Burgess J . Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir Res. 2010; 11:131. PMC: 2954923. DOI: 10.1186/1465-9921-11-131. View

3.
MacNee W . Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?. Ann Am Thorac Soc. 2016; 13 Suppl 5:S429-S437. DOI: 10.1513/AnnalsATS.201602-124AW. View

4.
Rivas M, Gupta G, Costanzo L, Ahmed H, Wyman A, Geraghty P . Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease. Medicina (Kaunas). 2022; 58(6). PMC: 9228143. DOI: 10.3390/medicina58060817. View

5.
Carlier F, De Fays C, Pilette C . Epithelial Barrier Dysfunction in Chronic Respiratory Diseases. Front Physiol. 2021; 12:691227. PMC: 8264588. DOI: 10.3389/fphys.2021.691227. View